$SYRE news

The latest SYRE stock news: headlines, filings, AI summaries and sentiment for $SYRE, updated around the clock.

• RenovoRx Reports Q3 2026 Revenue Growth and Maintains Full-Year Guidance Motley Fool · November 6, 2026, 17:13 UTC
• Spyre Therapeutics Reports Q3 GAAP EPS of -$0.94, Missing Estimates by $0.11 Seeking Alpha · November 3, 2026, 21:49 UTC
• Spyre Therapeutics, Inc. - 8-K Filing SEC EDGAR · November 3, 2026, 21:02 UTC
• Spyre Therapeutics, Inc. - 10-Q Filing SEC EDGAR · November 3, 2026, 21:01 UTC
• Spyre Therapeutics, Inc. - 8-K Filing SEC EDGAR · October 7, 2026, 12:01 UTC
• Spyre Therapeutics Prices $350 Million Public Offering at $85 Per Share Seeking Alpha · October 6, 2026, 04:25 UTC
• Spyre Therapeutics (SYRE) Completes Monotherapy Phase in IBD Portfolio Yahoo Finance · September 17, 2026, 07:04 UTC
• Spyre Therapeutics, Inc. - 8-K Filing SEC EDGAR · September 8, 2026, 12:03 UTC
• Spyre Therapeutics Shares Drop After Mixed Phase 2 Trial Results Seeking Alpha · August 25, 2026, 21:01 UTC
• Spyre Therapeutics, Inc. - 8-K Filing SEC EDGAR · August 25, 2026, 20:05 UTC
• Spyre Therapeutics, Inc. - 8-K Filing SEC EDGAR · June 1, 2026, 20:04 UTC